Cryptocurrency giant JASMY surpasses $72 billion market cap. Meanwhile, 23andMe's stock plummeted after a disastrous IPO, losing its $6B valuation and becoming a penny stock. WSJ explores the factors behind 23andMe's collapse, focusing on its genetic testing business and the challenges it faced.